CME Group (CME) director adds shares via market buys and equity awards
Rhea-AI Filing Summary
CME Group Inc. director William R. Shepard increased his stake in the company through a mix of market purchases and stock awards. On June 25, 2026, he made open-market purchases totaling 339.0999 shares of Class A common stock at $230.57 per share, including shares held indirectly through a trust.
On the same date he also acquired 1,067.0000 shares at a reference price of $225.00 per share through fully vested equity awards, shares taken in lieu of cash board retainers, and a dividend reinvestment plan under CME’s non‑employee director programs. Following these transactions, holdings reported include 260,442.3220 shares indirectly by trust and 3,620.7680 shares directly, indicating these moves are small relative to his overall position and largely compensation related.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,406.1 shares
Net Buy
4 txns
Insider
SHEPARD WILLIAM R
Role
Director
Bought
339.1 shs ($78K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock Class A | 645 | $225.00 | $145K |
| Grant/Award | Common Stock Class A | 422 | $225.00 | $95K |
| Purchase | Common Stock Class A | 14.318 | $230.57 | $3K |
| Purchase | Common Stock Class A | 324.782 | $230.57 | $75K |
Holdings After Transaction:
Common Stock Class A — 3,620.768 shares (Direct);
Common Stock Class A — 260,442.322 shares (Indirect, by Trust)
Footnotes (3)
- F1. Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.
- F2. At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant.
- F3. Represents shares acquired pursuant to a broker-administered dividend reinvestment plan.
Key Figures
Open-market shares purchased: 339.0999 shares
Open-market purchase price: $230.57 per share
Equity awards and related shares: 1,067.0000 shares
+3 more
6 metrics
Open-market shares purchased
339.0999 shares
Class A common stock bought on June 25, 2026
Open-market purchase price
$230.57 per share
Price for Class A shares bought June 25, 2026
Equity awards and related shares
1,067.0000 shares
Grants, fee-in-shares, and dividend reinvestment at $225.00
Award reference price
$225.00 per share
Price used to determine director equity awards
Indirect holdings after transaction
260,442.3220 shares
Class A shares held indirectly by trust post-transaction
Direct holdings after transaction
3,620.7680 shares
Class A shares held directly post-transaction
Key Terms
open-market purchase, Grant, award, or other acquisition, annual equity compensation program, Director Stock Plan, +1 more
5 terms
open-market purchase financial
"transaction_action: open-market purchase"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
annual equity compensation program financial
"issued as part of the Issuer's annual equity compensation program for non-employee directors"
Director Stock Plan financial
"under the CME Group Director Stock Plan"
dividend reinvestment plan financial
"Represents shares acquired pursuant to a broker-administered dividend reinvestment plan"
A dividend reinvestment plan lets shareholders automatically use cash dividends to buy more shares of the same company instead of receiving the money. It matters to investors because it turns regular payouts into a steady way to grow ownership and take advantage of compound returns—like having your savings automatically buy additional slices of a pie over time—while often reducing transaction costs and smoothing purchase timing.
FAQ
What did CME (CME) director William R. Shepard do in this Form 4?
William R. Shepard increased his CME holdings through open-market purchases and stock awards. He bought shares at $230.57 and received fully vested equity grants and dividend reinvestment shares under director compensation programs.
What stock awards did William R. Shepard receive from CME (CME)?
He acquired 1,067.0000 CME Class A shares via director compensation arrangements. These included fully vested equity grants, shares taken instead of cash retainers, and shares credited through a broker-administered dividend reinvestment plan.
What are William R. Shepard’s CME (CME) holdings after these transactions?
After the transactions, reported holdings include 260,442.3220 CME Class A shares held indirectly by a trust and 3,620.7680 shares held directly. This shows the new transactions are small compared with his total reported position.
How were some of William R. Shepard’s CME (CME) director fees paid?
At his election, some board cash retainers were taken in CME shares instead of cash. The number of shares was calculated by dividing the retainer amount by CME’s closing stock price on the grant date, according to the disclosure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
